麻豆传媒

Role

I complete horizon scanning - sometimes known as futures studies/foresight - for novel pharmaceuticals and MedTech (devices, diagnostics and digital tools). My core work at NIHR Innovation Observatory is the initial step for the National Institute for Health and Care Excellence (NICE) health technology appraisal process, which involves the evaluation of medicines coming to UK market. I also partake in ad-hoc horizon scan requests, to facilitate complete healthcare pathways, by identifying emerging MedTech that is complementary to the evolving therapeutic landscape. These horizon scans help support stakeholders' decision-making and preparedness key healthcare concerns, such as antimicrobial resistance, epidemics, early diagnoses, and adoption of artificial intelligence.

About the NIHR Innovation Observatory

The NIHR Innovation Observatory is a world leading health and care innovation scanning centre providing data-driven insights to foster innovation and equitable access to high quality care. We aim to transform health systems and improve population health by providing advanced data-driven insights that foster innovation and equitable access to high quality care. At the core of our work is the development of data-driven methods to identify, capture and synthesise intelligence on new health innovations. We develop and share cutting edge methods in horizon scanning, building capacity in the systems across the public, voluntary and industry sectors.

We deliver essential intelligence and insights about medicines and MedTech innovation to the National Institute of Health and Care Excellence (NICE), NHS England, the Medicines and Healthcare Products Regulatory Agency (MHRA), the NIHR, the UK Health Security Agency, the Department for Health and Social Care and industry - allowing these organisations to prepare for policies, regulation and frontline delivery for new, emerging and disruptive technologies.

• Article

  • Oyewole AO, Barrass L, Robertson EG, Woltmann J, O'Keefe H, Sarpal H, Dangova K, Richmond C, Craig D. . Diagnostics 2021, 11(2), 182.